The Australian Venom Research Unit (AVRU) has a small core of full-time research fellows, assisted and supported by our main internal collaborator, Associate Professor Christine Wright, and by the head and deputy head of the Department of Pharmacology and Therapeutics, Professor Daniel Hoyer and Associate Professor James Ziogas.
Our activities are supported by lab assistants and casual technical staff, and in Papua New Guinea we work with three full-time lab staff, a doctor and an intensive care nursing officer, along with casual clinical and support staff. AVRU has a network of Australian and international honorary research fellows with medical or scientific backgrounds.
The AVRU Team
Postdoctoral Fellows and Research Assistants
Ms Diana Barr
Dr David Williams (AVRU Head)
In addition to his role as the head of AVRU, Dr Williams leads the Charles Campbell Toxinology Centre (CCTC) at the School of Medicine and Health Sciences at the University of Papua New Guinea, where he manages AVRU’s 13-year snakebite project in PNG. Dr Williams is also CEO of the internationally active non-profit organisation the Global Snakebite Initiative (GSI), which promotes greater recognition of the public health impact of snakebite envenoming in the developing world, and seeks partnership to create solutions. Through engagement with the World Health Organization (WHO), WHO Member States, civil society, advocacy groups and a network of researchers and medical professionals, Dr Williams has contributed to the impending return of snakebite to the WHO list of Neglected Tropical Diseases, and is now working to secure the requisite Member State support for a resolution to direct comprehensive action on snakebite by the WHO at the 2018 World Health Assembly. Dr Williams chairs the WHO committee for the evaluation of antivenom product dossiers for Sub-Saharan Africa, and was editor of the second edition of the WHO Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins and temporary advisor on antivenoms to the 2016 WHO Expert Committee on Biological Standardization. In December 2017 he was selected by WHO to chair their new Snakebite Envenoming Working Group (SBE-WG) which has been tasked with developing a comprehensive road map strategy to reduce and control the global burden this neglected tropical disease.
Prior to AVRU's current engagement with the WHO, Dr Williams had held positions on previous WHO committees and working groups, and been engaged as a consultant. He was a facilitator of the WHO Bi‐Regional Workshop on the Production, Control, and Regulation of Antivenoms (Jakarta, Indonesia, 2008); contributed to the 1st edition of the WHO Guidelines for the Production, Control and Regulation of Snake Antivenom Immunoglobulins (2008-10); was an advisor to the WHO Expert Committee on Biological Standardization (2008); Consultant Toxinologist to the WHO Country Office for Cambodia and the Cambodian Ministry of Health (2008-2009) and was employed by WHO as Technical Officer (Snake Antivenoms) in the Essential Medicines and Health Technologies Department in Geneva (2009-2010), during a sabbatical from AVRU.
At AVRU Dr Williams leads teams focussed on preclinical and clinical toxinology research as well as venomous injury surveillance, venomics, antivenomics, and education of medical professionals and community members. He joined academia in 1999 after having worked in zoos, public exhibits and venom production laboratories as a herpetologist specialising in venomous snakes for most of his adult life. At James Cook University (JCU), he pursued an interest in snakebite by undertaking an epidemiological study of snakebite envenoming in rural Papua New Guinea (PNG). This was followed by a prospective clinical study of snake bite envenoming at Port Moresby General Hospital (PMGH) during his PhD project (2005-2009). He has been instrumental in establishing many of AVRU's key international collaborations and has managed the PNG Snakebite Research Project since 2004. This project led to a three way partnership between the University of Melbourne, University of PNG and the Instituto Clodomiro Picado (Universidad de Costa Rica), which resulted in successful development of the first new snake antivenom for human use in Australasia since 1960.
His work on snakebite in PNG has led to tangible improvements in the treatment of patients, which have significantly reduced case fatality rates, resulted in new standard protocols for patient treatment, established functional infrastructure that supports basic and clinical research projects, and have been translated into modern snakebite treatment facilities and remote emergency medical retrieval services. Internationally, he is well-regarded for his advocacy for the plight of snake bite victims in the developing world in his role with GSI and for his contributions to the development of new, innovative strategies for improving access to life-saving antivenoms. He coordinates the curriculum for PNG's National Snakebite Management Course and was the senior editor and author of Venomous Bites and Stings in Papua New Guinea, PNG’s first textbook on the treatment of envenoming, published in 2005.
Dr Timothy Jackson
Dr Timothy Jackson is an evolutionary toxinologist who has been publishing in the field since 2003. He received his PhD from the University of Queensland in 2016 for his thesis entitled “A philosophical and empirical investigation of the toxicoferan reptile venom system.” He holds undergraduate degrees from the University of Sydney (BA with majors in Music and Biology) and University of Queensland (BSc with first class honours in evolutionary biology).
His work focuses on the evolution of reptile venom systems and their constituent toxins and has resulted in the publication of 28 peer-reviewed papers and contributions to 26 book chapters to-date. Having grown up largely in Australia, working with Australian venomous snakes from a young age, a particular focus of Dr Jackson’s work has been the evolution of the venom of Australian elapid snakes and its connection with their ecological and behavioural diversity.
He is passionate in his belief that a deep understanding of the evolution of venoms and their constituent toxins can make an important contribution to the treatment of snakebite. In addition, his work on the molecular evolution of toxin genes focuses on treating them as a model system for molecular evolutionary processes in general.
Dr Jackson’s areas of expertise include evolutionary biology (evolutionary theory, molecular evolution and organismal biology), venomics (proteomics and transcriptomics), bioinformatics and computational biology, toxin structure-function and evolution, anatomy of reptilian venom systems, philosophy of science and animal husbandry.
In 2017 Dr Jackson joined AVRU, where he will continue his evolutionary research and head the Venoms and Antivenoms Reference Laboratory, which will characterise the venoms of medically important venomous snakes, evaluate antivenom efficacy, and generate the reference standards for the National Reference Venom Collection for Australia (NRVCA).
Dr Andrew Watt
Dr Andrew Watt is a medical researcher with a background in neuroscience, proteomics and clinical research. He received his PhD from the University of Melbourne in 2014 for his work focusing on the development of a blood test for Alzheimer’s disease and independent analysis of antibody-based therapies. Andrew holds a Bachelor of Science from Monash University and a BSc (1st class honours) from the University of Melbourne. He has also been teaching within the University of Melbourne’s Medical Doctorate program since 2010.
Andrew joined AVRU in 2017 and is focused on utilising epidemiological data to drive clinical improvements for snakebite patients. Using regional snakebite incidence data, he is working to ensure that local hospitals and health centres have adequate supplies of life-saving anti-venom across Papua New Guinea.
Engagement is also a large part of Andrew’s role with AVRU and he can often be found traveling to universities and schools around Australia to discuss the global impact of snakebite with students, clinicians and researchers alike.
Ms Krutika Wikhe
Krutika Wikhe is a medical researcher with a background in neuroscience, proteomics and molecular biology. She received a Master of Science from RMIT in 2007 which included a year’s research with the CSIRO. Krutika has more than a decade of experience working across academia and industry (Eli Lilly) in Singapore and Australia.
Krutika Wikhe joined AVRU in late 2017 and has been involved in setting up the new lab space. She will be managing the venomics and antivenomics lab setup along with carrying out the wet lab research. Krutika has also got significant experience as a lab supervisor. Her expertise in this area will be utilised to train and oversee the graduate students joining our team.